ATE219683T1 - Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten - Google Patents

Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten

Info

Publication number
ATE219683T1
ATE219683T1 AT94914804T AT94914804T ATE219683T1 AT E219683 T1 ATE219683 T1 AT E219683T1 AT 94914804 T AT94914804 T AT 94914804T AT 94914804 T AT94914804 T AT 94914804T AT E219683 T1 ATE219683 T1 AT E219683T1
Authority
AT
Austria
Prior art keywords
autoimmune diseases
delaying
preparations
preventing autoimmune
methods useful
Prior art date
Application number
AT94914804T
Other languages
English (en)
Inventor
Noel K University Of Maclaren
Med P O Box Lab
Andrew Muir
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of ATE219683T1 publication Critical patent/ATE219683T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94914804T 1993-04-16 1994-04-15 Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten ATE219683T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/048,979 US5891435A (en) 1993-04-16 1993-04-16 Methods and compositions for delaying or preventing the onset of autoimmune disease
PCT/US1994/004179 WO1994023737A1 (en) 1993-04-16 1994-04-15 Methods and compositions for delaying or preventing the onset of autoimmune disease

Publications (1)

Publication Number Publication Date
ATE219683T1 true ATE219683T1 (de) 2002-07-15

Family

ID=21957455

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94914804T ATE219683T1 (de) 1993-04-16 1994-04-15 Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten

Country Status (8)

Country Link
US (1) US5891435A (de)
EP (1) EP0693933B1 (de)
JP (1) JP3001638B2 (de)
AT (1) ATE219683T1 (de)
CA (1) CA2160543C (de)
DE (1) DE69430868T2 (de)
DK (1) DK0693933T3 (de)
WO (1) WO1994023737A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094597B1 (en) * 1994-05-20 2006-08-22 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
US5773570A (en) * 1994-05-20 1998-06-30 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
WO1997002043A1 (en) * 1995-06-30 1997-01-23 Novo Nordisk A/S Prevention of a disease having the characteristics of diabetes
US20020098194A1 (en) * 1996-03-21 2002-07-25 Paul V. Lehmann Methods for inducing immunity
CA2317674A1 (en) * 1998-01-08 1999-07-15 William Clifford Duckworth Methods and compositions for treating and diagnosing insulin related disorders
JP2002513765A (ja) * 1998-05-07 2002-05-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 免疫応答の調節における無視された標的組織抗原の使用
ATE453404T1 (de) * 1999-03-12 2010-01-15 Univ Leland Stanford Junior Dna-impfung zur behandlung von autoimmunerkrankungen
US7030098B2 (en) 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
US6884785B2 (en) * 1999-06-17 2005-04-26 The Scripps Research Institute Compositions and methods for the treatment or prevention of autoimmune diabetes
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
WO2001034188A1 (en) * 1999-11-12 2001-05-17 University Of Hawaii Malaria vaccine
US7608683B2 (en) * 2000-08-09 2009-10-27 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
US6989146B2 (en) * 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
CA2427572A1 (en) 2000-11-01 2002-05-10 The Regents Of The University Of California Immunomodulatory peptides derived from heat shock proteins and uses thereof
KR100729645B1 (ko) * 2000-12-29 2007-06-18 주식회사 녹십자홀딩스 글루타민산 데카르복실라제를 코딩하는 유전자가 삽입된재조합 백시니아 바이러스 및 이를 포함하는 제 1형당뇨병 예방 백신
AU2002249895A1 (en) * 2001-01-05 2002-07-16 Joslin Diabetes Center, Inc. Autoantigen composition
CA2524615A1 (en) * 2003-05-12 2004-11-18 Tolerogen, Ltd. Immunoglobulin conjugates of autoantigens and their use in the prevention of disease
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
ES2614931T3 (es) 2006-08-04 2017-06-02 Beth Israel Deaconess Medical Center Inhibidores de la piruvato cinasa y métodos de tratamiento de enfermedad
JP2011503232A (ja) 2007-11-20 2011-01-27 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 免疫応答の調節
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
EP2889039B1 (de) * 2012-08-22 2017-11-08 Regimmune Corporation Präparat zur vorbeugung oder behandlung von typ-1-diabetes
US20160193328A1 (en) * 2013-08-14 2016-07-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Immunoadjuvant Compositions and uses Thereof
US20180071376A1 (en) * 2015-03-23 2018-03-15 The Brigham And Women`S Hospital, Inc. Tolerogenic nanoparticles for treating diabetes mellitus

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
US4464363A (en) * 1979-12-20 1984-08-07 Merck & Co., Inc. Ajuvants for rectal delivery of drug substances
ZA808097B (en) * 1980-12-29 1982-01-27 Lilly Co Eli Novel insulin formulations
JPS58189121A (ja) * 1982-04-30 1983-11-04 Ajinomoto Co Inc インシユリン投与賦活剤
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
SU1624511A1 (ru) * 1989-02-14 1991-01-30 Донецкий государственный медицинский институт им.М.Горького Способ моделировани сахарного диабета
ATE250133T1 (de) * 1989-06-19 2003-10-15 Whitehead Biomedical Inst Verktorvermittelte genominsertion und expression von dna in bcg
ATE158950T1 (de) * 1989-07-14 1997-10-15 Autoimmune Inc Behandlung der autoimmunen uveoretinitis in menschen
AU651097B2 (en) * 1990-03-02 1994-07-14 Autoimmune, Inc. Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
IL97709A (en) * 1990-03-30 2005-05-17 Brigham & Womens Hospital Use of an mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis
US5512447A (en) * 1990-09-07 1996-04-30 The Regents Of The University Of California Methods for the diagnosis and treatment of diabetes
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
DK0701569T3 (da) * 1992-12-03 2009-02-23 Univ California Forbedrede reagenser og fremgangsmåder til diagnosticering og behandling af diabetes og stiff man-syndrom
WO1995024216A1 (en) * 1994-03-07 1995-09-14 Auckland Uniservices Limited Prevention of diabetes

Also Published As

Publication number Publication date
WO1994023737A1 (en) 1994-10-27
EP0693933A1 (de) 1996-01-31
US5891435A (en) 1999-04-06
CA2160543A1 (en) 1994-10-27
JP3001638B2 (ja) 2000-01-24
DK0693933T3 (da) 2002-10-21
EP0693933B1 (de) 2002-06-26
DE69430868D1 (de) 2002-08-01
DE69430868T2 (de) 2003-01-30
JPH08508036A (ja) 1996-08-27
CA2160543C (en) 2002-07-30

Similar Documents

Publication Publication Date Title
ATE219683T1 (de) Verfahren und zubereitungen zur verzoegerung oder vorbeugung von autoimmun krankheiten
ATE415173T1 (de) Pan dr-bindeproteinen zur erhöhung der immunantwort
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
EP0651818A4 (de) Immunogene peptide, antikörper sowie deren verwendungen im zusammenhang mit der cd4-rezeptorbindung.
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
CA2290485A1 (en) Method for the production of non-immunogenic proteins
DE69521796D1 (de) Behandlung des partiellen wachstumshormon-unempfindlichkeitssyndromes
ATE127345T1 (de) Stressproteine und verwendungen dafür.
EP1418235A3 (de) Intrazellular Domäne des her-2/neu Proteins, für die Prevention oder Behandlung von bösartigen Tumoren
KR970706842A (ko) 아실화된 인슐린 동족체(Acylated Insulin Analogs)
EP1440980A3 (de) Peptidanaloge des menschlichen, basischen Myelinproteins
EP0342860A3 (de) Neues Protein, Sequenze mit enthaltendem Gene, Vektoren, Verfahren zur Herstellung und Verwendung
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
NO952336L (no) Insulin analoger
GR3003060T3 (en) Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
AU684317B2 (en) Coccidiosis poultry vaccine
EP0770624A3 (de) Peptid das eine Immunantwort gegen menschlichen Magenkrebs induziert und Arzneimittel die es enthält zur Vorbeugung oder Behandlung von Magenkrebs
AU5628796A (en) Coccidiosis poultry vaccine
NZ221379A (en) Nematode plasma membrane-associated protein, extraction method and vaccines containing it
WO1996018646A3 (en) Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
AU2105888A (en) Synthetic peptides, antibodies directed against them, and the use thereof
DK0378432T3 (da) Peptider, deres anvendelse til inhibering af modningen af T-lymfocytter og aktiviteten af makrofager samt fremgangsmåder til deres fremstilling
AU3172095A (en) Coccidiosis poultry vaccine
WO1989000166A3 (en) Growth hormone related peptide

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee